<?xml version="1.0" encoding="utf-8"?>
<items><story><date>10:27 03 January 2007 (UTC)</date><text> (Adds details) Jan 3 (Reuters) -                    MERCK &amp; CO. INC. (MRK.N)                    Current          Prior
 Rating                Outperform       Peer perform --Bear Stearns said it sees upside to several new products
as consensus appears to be underestimating performance. The
drugmaker's Januvia treatment for diabetes and vaccines are new
pillars of growth, the brokerage said. --The brokerage raised its 2007 earnings estimate on the
company to $2.64 from $2.62, and for 2008 to $2.82 from $2.72.
Bear Stearns has a price target of $53 on the stock.
 (Reporting by Neha Singh in Bangalore)


</text><link>http://www.reuters.com/article/2007/01/03/merck-research-bearstearns-idUSBNG17300720070103</link><sectors></sectors><title>update 1 - research alert - bear stearns ups merck to outperform</title></story></items>